337 reports of this reaction
2.0% of all PYRIDOSTIGMINE BROMIDE reports
#11 most reported adverse reaction
FALL is the #11 most commonly reported adverse reaction for PYRIDOSTIGMINE BROMIDE. There are 337 FDA adverse event reports linking PYRIDOSTIGMINE BROMIDE to FALL. This represents approximately 2.0% of all 16,739 adverse event reports for this drug.
Patients taking PYRIDOSTIGMINE BROMIDE who experience fall should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
FALL is a less commonly reported adverse event for PYRIDOSTIGMINE BROMIDE, but still significant enough to appear in the safety profile.
In addition to fall, the following adverse reactions have been reported for PYRIDOSTIGMINE BROMIDE:
The following drugs have also been linked to fall in FDA adverse event reports:
FALL has been reported as an adverse event in 337 FDA reports for PYRIDOSTIGMINE BROMIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
FALL accounts for approximately 2.0% of all adverse event reports for PYRIDOSTIGMINE BROMIDE, making it a notable side effect.
If you experience fall while taking PYRIDOSTIGMINE BROMIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.